The First Affiliated Hospital with Nanjing Medical University: Carcinoma, Non-Small-Cell Lung trials

The registry lists 11 Carcinoma, Non-Small-Cell Lung studies with The First Affiliated Hospital with Nanjing Medical University as lead sponsor. 3 are open to participants now and 0 have results posted.

Phase 2 6Phase 3 1No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Prospective, Single-arm, Phase II Clinical Study of Tislelizumab Combined With Anlotinib and Platinum-based Doublet Perioperative Therapy for Resectable Stage II-IIIB Driver Gene-negative NSCLCNot yet recruitingNCT06977828Phase 2
• Envafolimab Immunotherapy After ctDNA EGFR Clearance by Treatment With Almonertinib in EGFR-Mutant, PD-LI Positive NSCLCNot yet recruitingNCT05534113Phase 2
• Comparison of Segmentectomy Versus Lobectomy for Non-small Cell Lung Cancer ≤ 2 cm in the Middle Third of the Lung FieldRecruitingNCT04944563Not applicable
• Adjuvant Chemotherapy for High-Risk Pathologic Stage I Non-Squamous NSCLCCompletedNCT07250360
• Factors Determine the Feasibility and Surgical Margin Quality of Sublobar Resection for Non-small Cell Lung Cancer?CompletedNCT07005401
• Fruquintinib Combined With Sintilimab and Chemotherapy in the Treatment of Non-Small Cell Lung CancerStatus unknownNCT04956146Phase 2
• Sintilimab, Anlotinib Hydrochloride and Platinum-Containing Dual-Agent Chemotherapy in NSCLCStatus unknownNCT04846452Phase 2
• Combination Chemotherapy With or Without Anlotinib in the Maintenance Treatment of Non-Squamous Non-Small Cell Lung Cancer.Status unknownNCT04453423Phase 2
• Anlotinib Combined With Nivolumab for Non-Small Cell Lung CancerStatus unknownNCT04211896Phase 2
• Clinical Study of Anlotinib in Maintenance Treatment of Advanced NSCLCStatus unknownNCT03769805Not applicable
• Clinical Research of S-1 Versus Pemetrexed in the Maintenance Treatment of Advanced NSNSCLCStatus unknownNCT03700333Phase 3